Rare diseases
Investigational molecules
Locations
Back to Portugal25 clinical trials in Faro, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
PortugalStudy on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
PortugalStudy of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease
PortugalPhase III Study Comparing FOLFOX Plus Panitumumab Followed by FOLFIRI Plus Bevacizumab Versus FOLFOX Plus Bevacizumab Followed by FOLFIRI Plus Panitumumab in Wild-Type RAS Metastatic Colorectal Cancer
PortugalStudy of ABBV-CLS-628 to evaluate safety and effectiveness in adults with Autosomal Dominant Polycystic Kidney Disease
PortugalStudy Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence
PortugalStudy on Sotagliflozin for Improving Symptoms in Patients with Hypertrophic Cardiomyopathy
PortugalStudy on Durvalumab, Tremelimumab, and Enfortumab Vedotin for Patients with Muscle Invasive Bladder Cancer Ineligible or Refusing Cisplatin
PortugalStudy on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19
PortugalStudy of Retifanlimab, INCAGN02385, and INCAGN02390 for First-Line Treatment in Patients with PD-L1 Positive Recurrent/Metastatic Head and Neck Cancer
PortugalStudy on the Effectiveness and Safety of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus
PortugalStudy of RO7790121 Treatment for Adults with Moderate to Severe Ulcerative Colitis: Testing Effectiveness and Safety in Initial and Long-term Therapy
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on hypertrophic cardiomyopathy and stroke prevention. Research includes evaluation of new treatments for both obstructive and non-obstructive cardiomyopathy, plus advanced therapies for post-stroke care.
Trials aim to improve patient outcomes and quality of life through targeted therapeutic approaches.
Comprehensive research in bladder cancer and head and neck cancers, exploring innovative combination therapies and immunotherapy approaches.
Focus on developing effective treatments for patients ineligible for standard therapies.
Advanced studies in systemic lupus erythematosus and allergic conditions, investigating novel therapeutic approaches and long-term treatment solutions.
Emphasis on improving patient outcomes through targeted immunological interventions.
Critical research focusing on COVID-19 treatments, particularly for severe cases and immunocompromised patients.
Trials designed to address both moderate and severe disease manifestations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
